Illumina Inc (ILMN)

12:49 PM

Is Illumina Inc. a good long term investmentMarket-beating returns - Autocar Professional

12:49 PM

07:42 AM

ILLUMINA, INC. (ILMN) - MSN

07:42 AM

07:19 AM

Whole Genome Sequencing Market Booming, to Reach US$ 8,608 - openPR.com

07:19 AM

07:04 AM

Multi-Omics Market Attracts Big Players, to Hit $33.25B by 2033 | - openPR.com

07:04 AM

05:35 AM

What analysts say about Illumina Inc. stockOutstanding growth strategies - Autocar Professional

05:35 AM

Jul 22, 2025

What drives Illumina Inc. stock priceBreakneck growth rates - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Lobbying Update: $410,000 of ILLUMINA INC. lobbying was just disclosed - Quiver Quantitative

Jul 22, 2025

Jul 22, 2025

DNA Test Kits Market Booming with Consumer Genomics Demand - openPR.com

Jul 22, 2025

Jul 22, 2025

Bioinformatics Services Market Surge Backed by Genomics - openPR.com

Jul 22, 2025

Jul 22, 2025

Illumina Inc. Stock Analysis and ForecastUnstoppable profit momentum - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Illumina India Wins the Top GCC Award at the 2025 GCC Workplace Awards - ThePrint

Jul 22, 2025

Jul 21, 2025

Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025 - GlobeNewswire Inc.

Jul 21, 2025

Jul 18, 2025

Published on: 2025-07-19 09:23:06 - jammulinksnews.com

Jul 18, 2025

Jul 18, 2025

Killer acquisitions: what the future holds post-Illumina — Consumer Competition Market Blog - Faculteit Rechtsgeleerdheid en Criminologische Wetenschappen

Jul 18, 2025

Jul 18, 2025

Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - Yahoo Finance

Jul 18, 2025

Jul 17, 2025

Illumina’s SWOT analysis: genomics giant faces headwinds as stock outlook shifts - Investing.com

Jul 17, 2025

Jul 17, 2025

March 2026 Options Now Available For Illumina (ILMN) - Nasdaq

Jul 17, 2025

Jul 17, 2025

Illumina Stock: What Went Wrong And Why It's Best To Stay Away - 富途牛牛

Jul 17, 2025

Jul 16, 2025

Single-Cell Omics Market Growth in Future Scope 2025-2032 |10x - openPR.com

Jul 16, 2025

Jul 15, 2025

DNA Microarray Market Size, Industry Growth Insights Report - openPR.com

Jul 15, 2025

Jul 14, 2025

Bioinformatics Market Set to Witness Significant Growth by 2033 - openPR.com

Jul 14, 2025

Jul 13, 2025

How To Trade (ILMN) - news.stocktradersdaily.com

Jul 13, 2025

Jul 12, 2025

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds - Seeking Alpha

Jul 12, 2025

Jul 11, 2025

Illumina stock downgraded at Scotiabank (ILMN:NASDAQ) - Seeking Alpha

Jul 11, 2025

Jul 11, 2025

Scotiabank Downgrades Illumina to Sector Perform From Sector Outperform, Reduces Price Target to $125 From $164 - MarketScreener

Jul 11, 2025

Jul 10, 2025

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025 - 富途牛牛

Jul 10, 2025

Jul 10, 2025

Industry Focus eBook: Infectious diseases - News-Medical

Jul 10, 2025

Jul 10, 2025

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year - PR Newswire

Jul 10, 2025

Jul 10, 2025

Illumina Achieves Double Recognition: #2 Most Sustainable US Company and Best Workplace Excellence - Stock Titan

Jul 10, 2025

Jul 09, 2025

Illumina, Inc.'s (NASDAQ:ILMN) Shareholders Might Be Looking For Exit - simplywall.st

Jul 09, 2025

Jul 09, 2025

Illumina Shares Fall After Citigroup Downgrade - MarketScreener

Jul 09, 2025

Jul 09, 2025

Why Illumina (ILMN) Shares Are Falling Today - Yahoo Finance

Jul 09, 2025

Jul 09, 2025

Illumina: Citigroup downgrades to 'Sell' Rating, The Target Price is $80 - AInvest

Jul 09, 2025

Jul 09, 2025

Illumina stock down as Citi cuts on recent rally (ILMN:NASDAQ) - Seeking Alpha

Jul 09, 2025

Jul 09, 2025

Illumina Shares Slip After Citi Issues Bearish Rating Ahead of Earnings - MSN

Jul 09, 2025

Jul 09, 2025

Illumina Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛

Jul 09, 2025

Jul 08, 2025

Where Illumina Stands With Analysts - Nasdaq

Jul 08, 2025